Kwick Forensic Share Price & Stock Analysis

Quick Answers

What is the Kwick Forensic share price today? Kwick Forensic is currently listed and trading. Check our charts for the latest listing performance.

Is Kwick Forensic a good stock to buy? Review our AI forensic scores and fundamental analysis for Kwick Forensic to understand the underlying financial health.

Key Stock Information

ViewIPO AI Analysis Score

The Kwick Forensic Stock scored 60/100 (Moderate Risk) in our deep analysis.

Frequently Asked Questions

What is the core business model of Kwick Forensic Solutions Ltd?

Kwick Forensic Solutions Ltd provides products, equipment, solutions, and rental services for forensic science, fingerprint analysis, cyber & digital forensics, and DNA analytics primarily to government law enforcement agencies and forensic laboratories.

What is the issue size and price band for the Kwick Forensic IPO?

The IPO has an issue size of ₹50.77 crore with a price band of ₹85 to ₹90 per share.

How will the proceeds from the Kwick Forensic IPO fresh issue be used?

The net proceeds from the fresh issue will primarily be used to meet the working capital requirements of the company (₹31.42 crore), alongside general corporate purposes.

What are the recent revenue and profit figures for Kwick Forensic Solutions?

Kwick Forensic Solutions reported revenue from operations of ₹30.18 crore in FY24, ₹65.03 crore in FY25, and ₹105.71 crore in FY26, with PAT growing from ₹2.83 crore to ₹13.51 crore over the same period.

Who are the major customers of Kwick Forensic Solutions?

Its primary clients are government entities including police stations, central and state forensic science laboratories, fingerprint bureaus, crime investigation departments, and police training academies.

What are the key risk factors associated with Kwick Forensic Solutions Ltd?

Key risks include heavy client concentration (top 10 clients generate 77.64% of revenue), government procurement dependency (55.22% of revenue), vendor concentration, and geographical concentration in Bihar and Gujarat.

View IPO
View IPO
Home›India›Kwick Forensic ()
Kwick Forensic Logo

Kwick ForensicNSE SME / BSE SME:

Analyzed by ViewIPO Financial Research Team
Forensic Technology & SolutionsIndiaFiled 2026-08-27Listed 2026-09-03Size Pending Data
Listing Price ₹168
Listing Return
₹60.00 (+66.67%)
Live Subscription
144.11x Total
Check Allotment
Status Link

Is Kwick Forensic a Good Stock? Quick Verdict

Kwick Forensic IPO scored 60/100 (Moderate Risk) in our deep analysis. The strongest pillar is Financial at 80/100, while Competition is the primary concern at 35/100. Kwick Forensic Solutions displays rapid operational growth and rising profitability in the forensic tech sector, balanced by notable customer, supplier, and government dependency risks.

Stock Score
60/100
Moderate Risk

Quick Verdict

Strong revenue trajectory, expanding from ₹30.18 Cr in FY24 to ₹105.71 Cr in FY26.
Significant profit expansion with PAT growing over 4.7x from ₹2.83 Cr in FY24 to ₹13.51 Cr in FY26.
High customer concentration with top 10 clients generating 77.64% of FY26 revenue.
Heavy dependency on government sector orders (55.22% of revenue in FY26).

Company Snapshot

Revenue (TTM)
₹105.71Cr↑ 62.56% YoY
Profitability
PositiveNet Income ₹13.51Cr
Gross Margin
29.56% 
Market Cap
—Pending Data
Issue Size
— 
Industry
Forensic Technology & Solutions 
P/E Ratio
—Pending Data

Risk Breakdown

Governance
65
Moderate
Financial
80
Excellent
Valuation
50
Expensive
Competition
35
High Risk
Dilution
60
Moderate
Promoter / Mgmt
60
Moderate

AI Summary

Kwick Forensic Solutions Ltd provides products, solutions, and technologies for forensic science, cyber investigation, DNA analysis, and mobile crime scene units primarily to Indian law enforcement agencies. The company experienced significant revenue growth from ₹30.18 crore in FY24 to ₹105.71 crore in FY26, alongside a net profit expansion from ₹2.83 crore to ₹13.51 crore. However, Kwick Forensic Solutions Ltd exhibits severe client concentration, with government clients generating 55.22% of revenue and top 10 customers accounting for 77.64% of total sales. The IPO proceeds of ₹50.77 crore are largely directed toward funding a ₹31.42 crore working capital requirement.

Overall Verdict: Kwick Forensic Solutions displays rapid operational growth and rising profitability in the forensic tech sector, balanced by notable customer, supplier, and government dependency risks.

Key Highlights

  • •Kwick Forensic Solutions supplies physical, digital, cyber, and DNA forensic technologies primarily to law enforcement agencies and laboratories.
  • •Total revenue grew at a robust rate from ₹30.18 crore in FY24 to ₹65.03 crore in FY25 and ₹105.71 crore in FY26.
  • •Profit after tax (PAT) scaled consistently from ₹2.83 crore in FY24 to ₹8.56 crore in FY25 and ₹13.51 crore in FY26.
  • •Maintains strategic OEM relationships with international companies including Thermo Fisher Scientific, Sirchie, and Rapiscan Systems.
  • •Domestic procurement of forensic kits and products increased to 91.35% of total purchases in FY26.
  • •Net proceeds from the fresh issue will primarily fund working capital requirements of ₹31.42 crore.

Financial Performance

Revenue (Annual)

↑ +62.6% YoY

INR in Crores

Net Income (Annual)

↑ +57.8% YoY

INR in Crores

Gross Margin (Annual)

↓ -2.7% Delta

In Percentage

EBITDA vs PAT

EBITDA YoY

INR in Crores

EBITDA
PAT

Listing Timeline

IPO Opens2026-08-27
IPO Closes2026-08-31
Basis of Allotment2026-09-01
Refunds & Demat2026-09-02
Listing Date2026-09-03

Valuation Analysis

Issue Price₹85 - ₹90
Estimated Fair Value
Pending Data
Valuation Premium
Pending
vs Fair Value

Stock DNA

Growth
58
Governance
65
Profitability
80
Valuation
50
Competition
35
Execution
60

Pros vs Cons

Pros

  • Consistent rapid growth in operating revenue, reaching ₹105.71 crore in FY26.
  • Sustained profitability expansion with FY26 net income standing at ₹13.51 crore.
  • Growing focus on localized in-house assembly and domestic procurement (91.35% of purchases in FY26).
  • Established non-exclusive technology distribution partnerships with leading global OEMs like Thermo Fisher and Rapiscan.

Cons

  • High customer concentration risk, with top 10 clients accounting for 77.64% of FY26 revenue.
  • Significant concentration of business with government entities (55.22% of FY26 sales), exposing firm to procurement policy shifts.
  • High vendor concentration, with top 10 suppliers driving 76.11% of material costs in FY26.
  • Geographical concentration in Bihar and Gujarat, which together accounted for 38.41% of total revenue in FY26.

Financial Health

Revenue Growth
CAGR >87% (FY24-FY26) (Excellent)
Debt Level
Outstanding Bank Guarantees of ₹5.93 Cr in FY26 (Moderate)
Cash & Equivalents
Undisclosed (Moderate)

Institutional Signals

Anchor Investors
Undisclosed
VC Backing Tier
None Disclosed
Strategic Partners
Strong (Sirchie, Thermo Fisher Scientific, Rapiscan Systems)

Kwick Forensic IPO Reddit Pulse & Sentiment

Real-time Reddit discussions & retail sentiment

No Public Data Available

We couldn't find any significant public discussions or retail sentiment threads for this IPO at the moment.

Disclaimer: These are raw community discussions aggregated from public forums. The AI summary and Reddit comments do not constitute financial advice. Always conduct your own independent research.

Kwick Forensic Stock — Frequently Asked Questions

Related Stock Reports

Zetwerk

Zetwerk

TEMPZET
0/100
View Report
Fusion CX

Fusion CX

FUSION
0/100
View Report
Ravita Engineering Services

Ravita Engineering Services

RAVITA
55/100
View Report
Vaibhav Vyapar

Vaibhav Vyapar

LOANFRONT
59/100
View Report
HD Fire Protect

HD Fire Protect

HDFIRE
59/100
View Report
View All Active & Upcoming Stocks & IPOs View Stock & IPO Calendar

Market Terminology Explained

Confused by terms like GMP, Kostak, or Subject to Sauda? Read our detailed guides in the IPO Glossary to understand the terminology before you invest.

Grey Market Premium (GMP)Subject to SaudaASBAOffer for Sale (OFS)
View Full Glossary

Source Citation: All financial data and risk metrics are derived from the official prospectus filed with the regulator (SEBI DRHP/RHP). ViewIPO algorithms process this public data for informational purposes. Not financial advice.

Want to analyze another stock or IPO?

Search any stock, IPO, company, ticker or filing and get instant AI-powered analysis.

Frequently Asked Questions about Kwick Forensic

What is the expected listing price of Kwick Forensic?

The expected listing price depends on the live Grey Market Premium. Check the live GMP and expected listing price for Kwick Forensic on our Live GMP Tracker.